Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.097,18
-0,05%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TherapeuticsMD Inc (TXMD) TherapeuticsMD Inc (TXMD) Notizie

TXMD

TherapeuticsMD (TXMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TXMD
DataOraFonteTitoloSimboloCompagnia
10/05/202422:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
10/05/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
10/05/202422:05Business WireTherapeuticsMD Announces First Quarter 2024 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/03/202421:00Business WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
07/12/202322:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
06/12/202317:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
17/11/202315:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
14/11/202322:05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
21/08/202322:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
14/08/202312:50Business WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/06/202323:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
28/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202323:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202322:05Business WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
04/05/202322:40Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXMDTherapeuticsMD Inc
01/05/202323:03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322:48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202322:01Business WireTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionNASDAQ:TXMDTherapeuticsMD Inc
31/03/202323:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TXMDTherapeuticsMD Inc
13/02/202323:25Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:TXMDTherapeuticsMD Inc
06/01/202323:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TXMDTherapeuticsMD Inc
03/01/202312:50Business WireTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202208:39TipRanksTherapeuticsMD Inks Licensing Deal with Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202200:00Business WireTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
14/11/202223:23Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TXMDTherapeuticsMD Inc
14/11/202222:05Business WireTherapeuticsMD Announces Third Quarter 2022 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
31/10/202211:50Business WireTherapeuticsMD Announces Additional $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
03/10/202212:50Business WireTherapeuticsMD Announces $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TXMD

La tua Cronologia

BIBX
JSTUSDT
JUST
EU
1915T
1915T
AQSE
TIA.GB
Tialis Essential IT
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network